Key result
Enrolment in a pharmacist-managed diabetes program reduced the relative risk of diabetes-related hospitalisations by 60% (RR 0.40) compared to the pre-intervention period in an underserved cohort.
Why the study?
Does a pharmacist-managed clinic improve HbA1c, blood pressure, and reduce diabetes-related hospitalizations in underserved adults with unmanaged type 2 diabetes mellitus?
Population
Underserved adults with unmanaged type 2 diabetes mellitus enrolled in a pharmacist-managed clinic for ≥12…
Comparison
Pharmacist-managed diabetes clinic program for… vs Pre-intervention baseline.
Design
Cohort
Follow-up
12 months
Authors
Loading...
Supports pharmacist-led diabetes care in underserved groups; leaves open need for RCTs to confirm benefit and causality.
Cohort (n=60)
No
Does a pharmacist-managed clinic improve HbA1c, blood pressure, and reduce diabetes-related hospitalizations in underserved adults with unmanaged type 2 diabetes mellitus?
Relative Risk: 0.4 (95% CI 0.2–0.83)
Absolute Event Rate: 8.3% vs 18.3%
p-value: p=0.013
A pharmacist-managed diabetes program significantly reduced HbA1c, blood pressure, and the risk of diabetes-related hospitalizations in an underserved cohort over 12 months.
Lefebvre et al. (2018) conducted a cohort in Type 2 diabetes mellitus (n=60). Pharmacist-managed diabetes clinic vs. Pre-intervention period was evaluated on Diabetes-related hospitalisations (RR 0.40, 95% CI 0.20-0.83, p=0.013). Enrolment in a pharmacist-managed diabetes program reduced the relative risk of diabetes-related hospitalisations by 60% (RR 0.40) compared to the pre-intervention period in an underserved cohort.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: